FDA
- Status: approved
Pylera based reduced regimen (Pylera based reduced regimen) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
American University of Beirut Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.